These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 3143076)

  • 41. Transgenic models of lymphoid neoplasia and development of a pan-hematopoietic vector.
    Adams JM; Harris AW; Strasser A; Ogilvy S; Cory S
    Oncogene; 1999 Sep; 18(38):5268-77. PubMed ID: 10498879
    [TBL] [Abstract][Full Text] [Related]  

  • 42. scl, a gene frequently activated in human T cell leukaemia, does not induce lymphomas in transgenic mice.
    Robb L; Rasko JE; Bath ML; Strasser A; Begley CG
    Oncogene; 1995 Jan; 10(1):205-9. PubMed ID: 7824274
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oncogene-induced liver neoplasia in transgenic mice.
    Sandgren EP; Quaife CJ; Pinkert CA; Palmiter RD; Brinster RL
    Oncogene; 1989 Jun; 4(6):715-24. PubMed ID: 2543942
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Id2 is dispensable for myc-induced lymphomagenesis.
    Nilsson JA; Nilsson LM; Keller U; Yokota Y; Boyd K; Cleveland JL
    Cancer Res; 2004 Oct; 64(20):7296-301. PubMed ID: 15492249
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lymphomagenesis in Emu-myc transgenic mice does not require transgene rearrangement or mutation of myc exon 1.
    Webb E; Barri G; Cory S; Adams JM
    Mol Biol Med; 1989 Dec; 6(6):475-80. PubMed ID: 2699507
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulatory elements in the immunoglobulin heavy chain gene 3'-enhancers induce c-myc deregulation and lymphomagenesis in murine B cells.
    Wang J; Boxer LM
    J Biol Chem; 2005 Apr; 280(13):12766-73. PubMed ID: 15687498
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Strain dependency of B and T lymphoma development in immunoglobulin heavy chain enhancer (E mu)-myc transgenic mice.
    Yukawa K; Kikutani H; Inomoto T; Uehira M; Bin SH; Akagi K; Yamamura K; Kishimoto T
    J Exp Med; 1989 Sep; 170(3):711-26. PubMed ID: 2504875
    [TBL] [Abstract][Full Text] [Related]  

  • 48. N-myc transgene promotes B lymphoid proliferation, elicits lymphomas and reveals cross-regulation with c-myc.
    Rosenbaum H; Webb E; Adams JM; Cory S; Harris AW
    EMBO J; 1989 Mar; 8(3):749-55. PubMed ID: 2785918
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice.
    Adams JM; Harris AW; Pinkert CA; Corcoran LM; Alexander WS; Cory S; Palmiter RD; Brinster RL
    Nature; 1985 Dec 12-18; 318(6046):533-8. PubMed ID: 3906410
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Overexpression of Frat1 in transgenic mice leads to glomerulosclerosis and nephrotic syndrome, and provides direct evidence for the involvement of Frat1 in lymphoma progression.
    Jonkers J; Weening JJ; van der Valk M; Bobeldijk R; Berns A
    Oncogene; 1999 Oct; 18(44):5982-90. PubMed ID: 10557087
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of the c-myc oncogene under control of an immunoglobulin enhancer in E mu-myc transgenic mice.
    Alexander WS; Schrader JW; Adams JM
    Mol Cell Biol; 1987 Apr; 7(4):1436-44. PubMed ID: 3037318
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [DNA replication and RNA transcription regulated by c-myc protein].
    Ariga H; Iguchi-Ariga MM
    Tanpakushitsu Kakusan Koso; 1989 Jul; 34(9):1163-74. PubMed ID: 2477871
    [No Abstract]   [Full Text] [Related]  

  • 53. An E mu-v-abl transgene elicits plasmacytomas in concert with an activated myc gene.
    Rosenbaum H; Harris AW; Bath ML; McNeall J; Webb E; Adams JM; Cory S
    EMBO J; 1990 Mar; 9(3):897-905. PubMed ID: 2155783
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunologic competence of B cells subjected to constitutive c-myc oncogene expression in immunoglobulin heavy chain enhancer myc transgenic mice.
    Vaux DL; Adams JM; Alexander WS; Pike BL
    J Immunol; 1987 Dec; 139(11):3854-60. PubMed ID: 2445821
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative action of myc and bcl-2 in B-cell malignancy.
    Klein G
    Cancer Cells; 1991 Apr; 3(4):141-3. PubMed ID: 1883686
    [No Abstract]   [Full Text] [Related]  

  • 56. Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors.
    van Lohuizen M; Verbeek S; Krimpenfort P; Domen J; Saris C; Radaszkiewicz T; Berns A
    Cell; 1989 Feb; 56(4):673-82. PubMed ID: 2537153
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pre-B cells in kappa-transgenic mice.
    Storb U; Denis KA; Brinster RL; Witte ON
    Nature; 1985 Jul 25-31; 316(6026):356-8. PubMed ID: 3927171
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differentiation of an Abelson virus-transformed immature B precursor cell line under the expression of tyrosine kinase activity of v-abl oncogene product.
    Maeda T; Owada MK; Sugiyama H; Miyake S; Tani Y; Ogawa H; Oka Y; Komori T; Soma T; Kishimoto S
    Cell Differ; 1987 Apr; 20(4):263-9. PubMed ID: 2438051
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice.
    Lovec H; Grzeschiczek A; Kowalski MB; Möröy T
    EMBO J; 1994 Aug; 13(15):3487-95. PubMed ID: 8062825
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging.
    van Lohuizen M; Verbeek S; Scheijen B; Wientjens E; van der Gulden H; Berns A
    Cell; 1991 May; 65(5):737-52. PubMed ID: 1904008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.